Skip to main content
VivoSim Labs, INC. logo

VivoSim Labs, INC. — Investor Relations & Filings

Ticker · VIVS ISIN · US68620A2033 US Professional, scientific and technical activities
Filings indexed 790 across all filing types
Latest filing 2018-05-17 Director's Dealing
Country US United States of America
Listing US VIVS

About VivoSim Labs, INC.

https://organovo.com/

VivoSim Labs, Inc. is a biotechnology services company that develops and utilizes bioprinted, three-dimensional (3D) human tissues designed to emulate human biology and disease. The company provides testing services for drugs and drug candidates, primarily for the pharmaceutical and biotechnology sectors. VivoSim Labs specializes in offering liver and intestinal toxicology insights through its proprietary New Approach Methodologies (NAMs), including its NAMkind™ 3D models. These non-animal testing platforms are used to generate human-relevant safety and toxicology data early in the drug discovery and development process, aiming to provide insights before animal studies or clinical trials.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2018-05-17 English
FORM 4 SUBMISSION
Director's Dealing
2018-05-17 English
FORM 4 SUBMISSION
Director's Dealing
2018-05-17 English
Regulatory Filings 2018
Regulatory Filings
2018-05-17 English
Regulatory Filings 2018
Regulatory Filings
2018-03-26 English
POS AM
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to a Form S-3 Registration Statement filed with the SEC. It relates to deregistration of unsold securities from a previously effective registration statement. The document is a regulatory filing concerning securities registration and deregistration, not a financial report, earnings release, or other report types. It is a formal SEC filing updating the status of securities registration, which fits the category of Regulatory Filings (RNS). The document length is 5635 characters, and it contains no financial statements or detailed financial data, only legal and regulatory information about the registration statement amendment.
2018-03-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.